)
Viking Therapeutics (VKTX) investor relations material
Viking Therapeutics Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Annual stockholder meeting scheduled for May 19, 2026, to be held virtually.
Proxy materials, including the annual report and proxy statement, are available online for review and voting.
Voting matters and shareholder proposals
Election of two Class II director nominees, J. Matthew Singleton and S. Kathryn Rouan, Ph.D., for terms expiring in 2029.
Ratification of CBIZ CPAs P.C. as independent registered public accounting firm for fiscal year ending December 31, 2026.
Advisory vote to approve compensation of named executive officers.
Board recommends voting for all nominees and proposals.
Board of directors and corporate governance
Board has nominated two individuals for Class II director positions with terms expiring in 2029.
- Annual meeting to elect directors, ratify auditor, and approve executive pay, with strong governance focus.VKTX
Proxy filing1 Apr 2026 - Rapid phase III progress and differentiated obesity therapies set up major 2026 data milestones.VKTX
Leerink Global Healthcare Conference 202624 Mar 2026 - VK2735 achieved up to 14.7% weight loss in Phase 2 obesity trials with strong tolerability.VKTX
Corporate presentation23 Mar 2026 - VK2735 advanced to Phase 3 with strong results and $706M cash to fund key milestones.VKTX
Q4 202512 Feb 2026 - Lead programs advance in obesity and NASH, with $942M cash supporting late-stage trials.VKTX
Q2 20243 Feb 2026 - Clinical programs show robust efficacy in NASH and obesity, with strong financial support.VKTX
Jefferies 2024 Global Healthcare Conference1 Feb 2026 - VK2809 met key efficacy and safety endpoints in NASH, showing strong histologic and metabolic benefits.VKTX
Study Result31 Jan 2026 - Obesity pipeline advances to late-stage trials, supported by strong data and regulatory alignment.VKTX
Morgan Stanley 22nd Annual Global Healthcare Conference22 Jan 2026 - Strong clinical progress and $930M cash position support advancing metabolic pipeline.VKTX
Q3 202419 Jan 2026
Next Viking Therapeutics earnings date
Next Viking Therapeutics earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage